GLP-1 medications are effective, but they arent accessible to everybody
In addition, exogenous IGF-1 administration has been shown to reduce serum glucose levels [95, 143, 144], not only in healthy individuals [140, 145147], but also in those with insulin resistance [148, 149], type I [150152], and T2D [153155]
Following observations in a clinical setting that some MS patients seemed to experience a lessening of fatigue while taking ASA for non-MS-related symptoms, a double-blind, randomized, crossover study of 650 mg oral ASA twice daily or placebo for 6 weeks was initiated, where a modest but detectable improvement was found during the treatment phase with ASA [176]
If you have been off the medication for two weeks or more and jump back in at a high dose, your body may react poorly
since August (six months) and have seen 2/3 of the doctors, as well as nutrition and IV